Evening of 25th September 2018
PEPTINOV Conference & Cocktail
Meet the management of two innovative start-ups, in the process of raising funds, one specializing in the treatment of chronic inflammatory diseases, the other in cancer treatments:
PEPTINOV is a biotechnology company specializing in the research and development of active immunotherapy for the treatment of chronic inflammatory diseases and in particular osteoarthritis.
René AZOULAI, General Director
Hervé DO, CFO and VP Business Development
Jean-François ZAGURY, Founder and Scientific Director
Access to peptinov documents on the crowdfunding website Happy Capital